{"id":"standardized-antihypertensive-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Cough (if ACE inhibitor-containing)"},{"rate":null,"effect":"Hyperkalemia (if ACE inhibitor or ARB-containing)"}]},"_chembl":{"chemblId":"CHEMBL4298181","moleculeType":"Gene"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This represents a standardized treatment protocol rather than a single drug entity, typically combining agents from classes such as ACE inhibitors, angiotensin receptor blockers, calcium channel blockers, beta-blockers, or diuretics. The mechanism depends on the specific agents included in the protocol, which work through various pathways including vasodilation, reduced cardiac output, or decreased fluid volume to lower blood pressure.","oneSentence":"Standardized antihypertensive therapy reduces blood pressure through one or more established pharmacological classes of antihypertensive agents.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:09:36.204Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension management"}]},"trialDetails":[{"nctId":"NCT07424118","phase":"NA","title":"REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription","status":"NOT_YET_RECRUITING","sponsor":"Evelyn Vanina Re","startDate":"2026-04","conditions":"Essential Hypertension","enrollment":240},{"nctId":"NCT05684055","phase":"NA","title":"\"Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2023-09-09","conditions":"Arterial Hypertension","enrollment":1354},{"nctId":"NCT07130955","phase":"NA","title":"A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Shanghai Golden Leaf MedTec Co. Ltd","startDate":"2025-08-08","conditions":"Hypertension, CKD - Chronic Kidney Disease","enrollment":236},{"nctId":"NCT06023576","phase":"PHASE2","title":"A Study of Blood Pressure Control During Cancer Treatment","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-08-18","conditions":"Breast Cancer, Cardiotoxicity","enrollment":130},{"nctId":"NCT07003763","phase":"NA","title":"Electroacupuncture on Treating Cancer-related Depression","status":"RECRUITING","sponsor":"Shanghai Municipal Hospital of Traditional Chinese Medicine","startDate":"2025-07-01","conditions":"Depression, Cancer","enrollment":86},{"nctId":"NCT03527719","phase":"NA","title":"China Rural Hypertension Control Project","status":"ACTIVE_NOT_RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2018-05-08","conditions":"Hypertension","enrollment":33995},{"nctId":"NCT06307574","phase":"NA","title":"bpMedManage: Digital Technology to Support Adherence to Hypertension Medications","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2024-02-29","conditions":"Aging, Mild Cognitive Impairment, Hypertension","enrollment":100},{"nctId":"NCT07108829","phase":"NA","title":"Laparoscopic Adventitial Renal Denervation (RDN) for Refractory Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2025-08","conditions":"Refractory Hypertension or Drug-intolerant Hypertension","enrollment":10},{"nctId":"NCT06859359","phase":"NA","title":"Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-06-02","conditions":"Hypertensive Disorder of Pregnancy","enrollment":1200},{"nctId":"NCT03127631","phase":"NA","title":"A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients","status":"RECRUITING","sponsor":"McMaster University","startDate":"2015-10-21","conditions":"Prostate Cancer, Cardiovascular Disease","enrollment":6000},{"nctId":"NCT06801249","phase":"PHASE4","title":"Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2021-02-23","conditions":"Adrenal Incidentalomas, Cushing Syndrome","enrollment":50},{"nctId":"NCT06790927","phase":"NA","title":"Standardized Antihypertensive Treatment Protocol","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2025-02-24","conditions":"Hypertension","enrollment":400},{"nctId":"NCT05011838","phase":"NA","title":"Evaluation of the Effectiveness of an Intervention to Reduce Gaps in Hypertension Care in Low-income Medellin, Colombia","status":"WITHDRAWN","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2023-02-14","conditions":"Hypertension","enrollment":""},{"nctId":"NCT01421771","phase":"NA","title":"Blood Pressure in Dialysis Patients","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2011-10","conditions":"Hypertension, Renal Failure Chronic Requiring Hemodialysis, Blood Pressure","enrollment":126},{"nctId":"NCT02605551","phase":"NA","title":"Hypertension and Osteopathic Treatment","status":"WITHDRAWN","sponsor":"Larkin Community Hospital","startDate":"2015-04-01","conditions":"Prehypertension, Hypertension, Osteopathic Manipulation","enrollment":""},{"nctId":"NCT05149781","phase":"","title":"Standardized Diagnosis and Treatment of Endocrine Hypertension","status":"UNKNOWN","sponsor":"Affiliated Hospital of Nantong University","startDate":"2021-08-01","conditions":"Endocrine Hypertension","enrollment":200},{"nctId":"NCT02364089","phase":"NA","title":"Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2015-04-09","conditions":"Adrenal Incidentalomas","enrollment":78},{"nctId":"NCT03261375","phase":"NA","title":"To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension","status":"COMPLETED","sponsor":"Shanghai Golden Leaf MedTec Co. Ltd","startDate":"2021-01-19","conditions":"Hypertension","enrollment":205},{"nctId":"NCT03868007","phase":"NA","title":"Protective Effects of RIC in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2019-03-10","conditions":"Elderly Patients, Acute Ischemic Stroke, Acute Coronary Syndrome","enrollment":80},{"nctId":"NCT01083017","phase":"","title":"Resistant Arterial Hypertension Cohort Study","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2011-04","conditions":"Hypertension, Essential Hypertension, Resistant Hypertension","enrollment":74},{"nctId":"NCT01570777","phase":"PHASE4","title":"Renal Denervation in Hypertension","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-04","conditions":"Hypertension, Resistant to Conventional Therapy, Renal Denervation","enrollment":121},{"nctId":"NCT03005470","phase":"PHASE3","title":"Technology for Innovative Monitoring of Cardiovascular Prevention: a RCT","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2017-01","conditions":"Blood Pressure, High, Prehypertension","enrollment":231},{"nctId":"NCT03428061","phase":"","title":"The ZWOlle Transmural Integrated Care for CArdiovaScular Risk Management Study","status":"UNKNOWN","sponsor":"UMC Utrecht","startDate":"2017-09-01","conditions":"Cardiovascular Diseases, Hypercholesterolemia, Hypertension","enrollment":740},{"nctId":"NCT02539810","phase":"PHASE4","title":"Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09","conditions":"Hypertension, Hypertension Resistant to Conventional Therapy, Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent","enrollment":4},{"nctId":"NCT00097955","phase":"PHASE2","title":"Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2004-10","conditions":"Diabetic Nephropathy","enrollment":496},{"nctId":"NCT00582777","phase":"PHASE2, PHASE3","title":"African American Study of Kidney Disease and Hypertension ABPM Pilot Study","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2007-11","conditions":"Hypertensive Renal Disease","enrollment":180}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":696,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standardized antihypertensive therapy","genericName":"Standardized antihypertensive therapy","companyName":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","companyId":"irccs-azienda-ospedaliero-universitaria-di-bologna","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standardized antihypertensive therapy reduces blood pressure through one or more established pharmacological classes of antihypertensive agents. Used for Hypertension management.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}